A study claimed that people who eat high-fat, low-carb diets weren’t seeing their arteries fill up with plaque, despite having high levels of blood cholesterol. Critics disagreed—and all hell broke loose.
Curious about mushroom supplements? Here's what they do, what the science says, and how to know if they're right for you—according to the experts.
Researchers are trying to understand more about the biological and social differences that contribute to later diabetes diagnoses and worse outcomes in women.
As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 medication injected daily instead of weekly.
Growing rates of type 2 diabetes across the African content offer scientists hope of creating new, more inclusive treatments.
Casey Means isn’t currently licensed as a doctor. But that’s not why anti-vaxxers and conspiracists think she’s unsuited to be surgeon general—to them, her anti-vaccine opinions aren't extreme enough.
CBP's acting commissioner has rescinded four Biden-era policies that aimed to protect vulnerable people in the agency's custody, including mothers, infants, and the elderly.
With measles on the rise, this episode of Uncanny Valley looks at RFK's role in the revival of the once-eliminated deadly illness.
NIAID's Integrated Research Facility is one of the few federal facilities charged with studying Ebola. Tuesday afternoon, all of its work was put on indefinite pause by RFK Jr.'s department.
The border state of Chihuahua has recorded 713 confirmed cases, with its outbreak linked to the ongoing cluster of cases north of the border in Texas.
